Skip to main content
letter
. 2019 Oct 6;11(3):748–749. doi: 10.1111/jdi.13143

Figure 1.

Figure 1

Daily changes in plasma glucose and serum C‐peptide levels after initiation of treatment of nivolumab. i.v., intravenous fluid.